Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of the National Cancer Institute

• Publication date

  2012-09-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JNCI/DJS351PMID 22933731PMCID PMC3529597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Medicine in the University

  2015cited by this paper
• Cancer Incidence in Five Continents Vol. X

  2013cited by this paper
• Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome

  2013cited by this paper
• Evidence for breast cancer as an integral part of lynch syndrome

  2012cited by this paper
• Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.

  2012cited by this paper
• Risk of Pancreatic Cancer in Families With Lynch Syndrome

  2011cited by this paper
• Cancer risks associated with germline mutations in MLH1, MSH2 and MSH6 genes in Lynch syndrome: results from the large nationwide French ERISCAM study

  2011cited by this paper
• Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

  2011cited by this paper
• BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

  2011cited by this paper
• Hereditary prostate cancer as a feature of Lynch Syndrome

  2011cited by this paper
• The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study

  2011cited by this paper
• Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers

  2010cited by this paper
• Risk of endometrial cancer for women diagnosed with HNPCC‐related colorectal carcinoma

  2010cited by this paper
• Lynch Syndrome–Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry

  2010cited by this paper
• Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery

  2010cited by this paper
• Risks of Lynch syndrome cancers for MSH6 mutation carriers.

  2010cited by this paper
• Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer

  2009cited by this paper
• Risk of pancreatic cancer in families with Lynch syndrome.

  2009cited by this paper
• Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome

  2008cited by this paper
• Small-bowel cancer in Lynch syndrome: is it time for surveillance?

  2008cited by this paper
• Association between colorectal cancer and urologic cancers.

  2008cited by this paper
• Small bowel cancer risk in Lynch syndrome

  2008cited by this paper
• Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer

  2008cited by this paper
• The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

  2008cited by this paper
• A Population-Based Analysis of Second Primary Cancers After Irradiation for Rectal Cancer

  2007cited by this paper
• Multiple Cancer Prevalence: A Growing Challenge in Long-term Survivorship

  2007cited by this paper
• Is surveillance of the small bowel indicated for Lynch syndrome families?

  2007cited by this paper
• Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer

  2007cited by this paper
• Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975–2001

  2006cited by this paper
• Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.

  2006cited by this paper
• German

  2006cited by this paper
• The Epidemiology of Second Primary Cancers

  2006cited by this paper
• Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

  2006cited by this paper
• Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study.

  2006cited by this paper
• Large genomic alterations in hMSH2 and hMLH1 in early‐onset colorectal cancer: identification of a large complex de novo hMLH1 alteration

  2006cited by this paper
• New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000.

  2006cited by this paper
• HNPCC-associated small bowel cancer: clinical and molecular characteristics.

  2005cited by this paper
• Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.

  2005cited by this paper
• Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia)

  2005cited by this paper
• Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment

  2005cited by this paper
• An appendix carcinoid tumor in a patient with hereditary nonpolyposis colorectal cancer.

  2004cited by this paper
• Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

  2004cited by this paper
• Cancer survivorship--United States, 1971-2001.

  2004cited by this paper
• Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.

  2004cited by this paper
• Hereditary colorectal cancer.

  2003cited by this paper
• Prostate cancer is part of the hereditary non‐polyposis colorectal cancer (HNPCC) tumor spectrum

  2003cited by this paper
• Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non‐polyposis colorectal cancer

  2003cited by this paper
• Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-polyposis colonic cancer.

  2002cited by this paper
• The risk of subsequent primary cancers after colorectal cancer in southeast England

  2002cited by this paper
• Cancer incidence in five continents. Volume VIII.

  2002cited by this paper
• Stata Statistical Software: Release 7.

  2001cited by this paper
• Statistical methods in cancer research

  2001cited by this paper
• Multiple primary cancer incidence in Italy.

  2001cited by this paper
• Second primary cancers after sporadic and familial colorectal cancer.

  2001cited by this paper
• Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non‐polyposis colorectal cancer

  2000cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• Cancer risk following polyps or cancer of the large bowel in Vaud, Switzerland

  1999cited by this paper
• The National Comprehensive Cancer Network

  1998cited by this paper
• Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma

  1998cited by this paper
• The epidemiology of cancer of the small bowel.

  1998cited by this paper
• Incidence of second primary cancers in three Italian population-based cancer registries.

  1997cited by this paper
• Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.

  1997cited by this paper
• Cancer Incidence in Five Continents

  1997cited by this paper
• Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome

  1996cited by this paper
• Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome

  1995cited by this paper
• Identification of a breast tumor with microsatellite instability in a potential carrier of the hereditary non‐polyposis colon cancer trait

  1995cited by this paper
• Impact of family history of colon cancer on development of multiple primaries after diagnosis of colon cancer

  1995cited by this paper
• The International Collaborative Group on HNPCC.

  1994cited by this paper
• Incidence of Second Primary Cancers in Osaka Residents, Japan, with Special Reference to Cumulative and Relative Risks

  1994cited by this paper
• Cancer incidence in five continents, vol. VI

  1993cited by this paper
• Multiple primary cancers in the Vaud Cancer Registry, Switzerland, 1974-89.

  1993cited by this paper
• Hereditary Colorectal Cancer

  1990cited by this paper
• The risk of subsequent primary malignant diseases after cancers of the colon and rectum a nationwide cohort study

  1990cited by this paper
• Statistical Methods in Cancer Research, Vol. II: The Design and Analysis of Cohort Studies.

  1990cited by this paper
• International Classification of Diseases for Oncology

  1990cited by this paper
• The design and analysis of cohort studies

  1987cited by this paper
• Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

  1987cited by this paper
• Multiple cancer--an epidemiologic exercise in Finland.

  1985cited by this paper
• Second cancer following cancer of the digestive system in Denmark, 1943-80.

  1985cited by this paper
• Second cancer following cancer of the digestive system in Connecticut, 1935-82.

  1985cited by this paper
• Cancer Incidence in Five Continents

  1970cited by this paper

• Subsequent primary cancer risks for non-hereditary colorectal cancer survivors

  2026cites this paper
• Lung adenocarcinoma and colorectal cancer as double primary malignancies reveal lynch syndrome: a case report of germline MLH1 mutation with response to immunotherapy and familial aggregation

  2026cites this paper
• Case Report: A case of Lynch syndrome-related glioblastoma with coexisting MSH2 splicing defect and MSH6 frameshift mutation

  2026influential citation
• Cost-effectiveness of Lynch syndrome screening in colorectal cancer: universal germline vs sequential screening.

  2025cites this paper
• MSH6 as a prognostic biomarker in bladder cancer and its correlation with immunity

  2025cites this paper
• The genetic puzzle of FAP: exploring novel diagnostic approaches for APC/MUTYH-negative case

  2025cites this paper
• Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer

  2025cites this paper
• Genotype-Phenotype Characterization of Lynch Syndrome-associated Upper Tract Urothelial Carcinoma.

  2025cites this paper
• Risks of colorectal and extracolonic cancers following colorectal cancer: a systematic review and meta-analysis

  2025cites this paper
• Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors

  2025cites this paper
• The usefulness of comprehensive genome profiling test in screening of Lynch syndrome independent of the conventional clinical screening or microsatellite instability tests

  2025cites this paper
• Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancer

  2025cites this paper
• Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma

  2024cites this paper
• Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.

  2024cites this paper
• Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer

  2024cites this paper
• Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome

  2024cites this paper
• Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report

  2024cites this paper
• A Prospective Study to Evaluate the Prevalence of Microsatellite Instability in Endometrial Carcinoma by using Immunohistochemistry for Mismatch Repair Proteins as a Surrogate Marker

  2024cites this paper
• The effect of thyroid cancer on the survival of patients with digestive system tumors using SEER database

  2024cites this paper
• Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)

  2024cites this paper
• MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome

  2023cites this paper
• Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer

  2023cites this paper
• Genotoxins: The Mechanistic Links between Escherichia coli and Colorectal Cancer

  2023influential citation
• Current status and perspectives of genetic testing in gastrointestinal cancer (Review)

  2023cites this paper
• Biological and Clinical Implications of Early-Onset Cancers: A Unique Subtype.

  2023cites this paper
• Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice

  2023cites this paper
• Lung Cancer in Patients With Lynch Syndrome: Association or Coincidence?

  2023cites this paper
• New Epidemiologic Trends in Cholangiocarcinoma.

  2023cites this paper
• A Japanese case of ovarian mucinous adenocarcinoma with germline double variants of MSH2 and BRCA2

  2023influential citation
• Penetrance of Gastric Adenocarcinoma Susceptibility Genes: A Systematic Review

  2022cites this paper
• Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.

  2022cites this paper
• Association of cancer with comorbid inflammatory conditions and treatment in patients with Lynch syndrome

  2022cites this paper
• Gynecological Cancers in Lynch Syndrome: A Comparison of the Histological Features with Sporadic Cases of the General Population

  2022cites this paper
• Mismatch repair is a double-edged sword in the battle against microsatellite instability

  2022cites this paper
• Subsequent primary cancer risk among five-year survivors of adolescent and young adult cancers.

  2022cites this paper
• Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures

  2022cites this paper
• Risk of extracolonic second primary cancers following a primary colorectal cancer: a systematic review and meta-analysis

  2022cites this paper
• Hereditary gynecologic tumors and precision cancer medicine

  2022cites this paper
• What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes

  2022cites this paper
• Bone Metastasis As the Initial Presentation of a Hidden Bronchogenic Carcinoma

  2022cites this paper
• NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ® ) Prostate Cancer Early Detection Version 1 . 2022 —

  2022cites this paper
• Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022

  2022cites this paper
• Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers

  2021cites this paper
• Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer

  2021cites this paper
• Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities?

  2021cites this paper
• Room for improvement: One third of Lynch syndrome patients presenting for genetic testing in a highly specialised centre in Stockholm already have cancer

  2021cites this paper
• Immunology of Lynch Syndrome

  2021cites this paper
• Challenges managing women with suspected Lynch Syndrome in Zimbabwe: a case report

  2021cites this paper
• The Frequency of DNA Mismatch Repair Deficiency Is Very Low in Surgically Resected Lung Carcinoma

  2021cites this paper
• Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk

  2021cites this paper
• Case–case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer

  2021cites this paper
• Investigation of Hereditary Cancer Predisposition Genes of Patients with Colorectal Cancer: Single-centre Experience.

  2021cites this paper
• Classification of MSH6 Variants of Uncertain Significance Using Functional Assays

  2021cites this paper
• A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

  2021cites this paper
• Molecular Features and Clinical Management of Hereditary Gynecological Cancers

  2020cites this paper
• Lynch Syndrome-Associated Urological Malignancies

  2020cites this paper
• The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcinoma following radical surgery.

  2020cites this paper
• Immune Checkpoint Inhibitor-Induced Polymyositis and Myasthenia Gravis with Fatal Outcome

  2020cites this paper
• Clinicopathological and molecular characteristics of prostate cancer diagnosed in young men aged up to 45 years

  2020cites this paper
• Double small bowel cancers leading to the diagnosis of Lynch syndrome with germline MSH6 mutation in an elderly patient

  2020cites this paper
• Spectrum and Frequency of Tumors, Cancer Risk and Survival in Chilean Families with Lynch Syndrome: Experience of the Implementation of a Registry

  2020cites this paper
• Identification of a Microsatellite Stable, EGFR-Mutant Lung Adenocarcinoma Developing in a Patient With Lynch Syndrome.

  2020cites this paper
• Colorectal Cancer in the Young: Epidemiology, Prevention, Management.

  2020cites this paper
• Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort

  2020cites this paper
• Loss of Mismatch-repair Protein Expression and Microsatellite Instability in Upper Tract Urothelial Carcinoma and Clinicopathologic Implications.

  2020cites this paper
• Management of Hereditary Colorectal Cancer: A Multidisciplinary Approach

  2020cites this paper
• Lynch Syndrome: Management of Rectum, What Operation?

  2020cites this paper
• Gastric Cancer in Young Adults: A Different Clinical Entity from Carcinogenesis to Prognosis

  2020cites this paper
• Cancer of the Small Bowel

  2020cites this paper
• Loss of DNA mismatch repair proteins in prostate cancer

  2020cites this paper
• CUAJ – Original Research Tam et al Relationship between location of urothelial cancer and OS

  2020cites this paper
• Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

  2019cites this paper
• Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab

  2019cites this paper
• Clinical implications of mismatch repair deficiency in prostate cancer.

  2019cites this paper
• Sex differences in upper tract urothelial carcinomas

  2019cites this paper
• Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers

  2019cites this paper
• Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology.

  2019cites this paper
• Response to Dominguez-Valentin M et al. 2019: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

  2019cites this paper
• Soft Tissue Fibroblastic Reticular Cell Tumor With Whole-Exome Sequencing Findings: An Unexpected Presentation of Lynch Syndrome

  2019cites this paper
• The impact of health anxiety on perceptions of personal and children’s health in parents with Lynch syndrome

  2019cites this paper
• ATM whole gene deletion in an Italian family with hereditary pancreatic cancer: Challenges to cancer risk prediction associated with an 11q22.3 microdeletion.

  2019cites this paper
• Title: Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers

  2019cites this paper
• Gene Panel Sequencing in a Chinese High-risk Breast Cancer Cohort

  2019cites this paper
• Whole-exome sequencing identified a novel mutation of MLH1 in an extended family with lynch syndrome

  2019influential citation
• Confirmation of damaging effect of MSH2 c.2634+1G>C mutation on splicing, its classification and implications for counseling.

  2019cites this paper
• Genética del carcinoma colorrectal con agregación familiar, en una muestra de la Región Andina colombiana

  2019cites this paper
• Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatment.

  2018cites this paper
• Update on Hereditary Colorectal Cancer: Improving the Clinical Utility of Multigene Panel Testing.

  2018cites this paper
• Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.

  2018cites this paper
• Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma

  2018cites this paper
• DNA repair defects in prostate cancer: impact for screening, prognostication and treatment

  2018cites this paper
• Cancer Risks for PMS2-Associated Lynch Syndrome.

  2018cites this paper
• Update on small bowel surveillance in hereditary colorectal cancer syndromes

  2018cites this paper
• The association between histological subtype of a first primary endometrial cancer and second cancer risk

  2018cites this paper
• Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels

  2018cites this paper
• Inherited forms of bladder cancer: a review of Lynch syndrome and other inherited conditions.

  2018cites this paper
• Surveillance Guidelines for Hereditary Colorectal Cancer Syndromes

  2018cites this paper
• Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome

  2018cites this paper
• The cause of the increased colon cancer mortality rate in Newfoundland & Labrador: a study comparing survival in Newfoundland & Labrador and Ontario population-based cohorts

  2018cites this paper
• Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes

  2018cites this paper